The Therapeutic Goods Administration (TGA) has announced a major enforcement enforcement operation targeting illegal peptides, declaring the unregulated substances a new priority focus area due to a sharp increase in imports and digital advertising.
The national medicines watchdog stated on Wednesday that peptides—frequently marketed online for athletic performance enhancement or anti-ageing benefits—are increasingly being unlawfully advertised and supplied to Australian consumers, creating significant safety risks.
Other therapeutic products currently listed as high-priority areas for the regulatory watchdog include melatonin, medicinal cannabis, and prescription weight loss medications.
Rising Evidence of Consumer Risk
TGA Chief, Professor Anthony Lawler, confirmed that the regulator is stepping up its enforcement posture in response to the growing market availability of unapproved products.
“As the availability of unapproved peptide products has increased, so too has evidence of potential risk to consumers,” Professor Lawler said.
The TGA’s expanded enforcement strategy targeting the import, supply, and domestic manufacture of unlawful peptides will involve coordinated product seizures, infringement notices, border interventions, and formal legal penalties.
Multi-Agency Enforcement Operations
The regulatory escalation follows a major multi-agency joint operation conducted in April, which involved the TGA, the Australian Border Force, and Victoria Police. The joint raids resulted in the seizure of illegal steroids and peptides valued at $2 million.
Despite the fact that these peptides are not approved for human use in Australia, the products have gained significant traction across social media platforms. High-profile digital influencers have reportedly been promoting injectable peptides to their audiences as a lifestyle product, describing them as a “glow up potion” capable of treating conditions ranging from chronic back pain to recurrent urinary tract infections (UTIs).
Regulatory investigations and compliance monitoring into online supply networks remain ongoing.